Literature DB >> 24100213

Cell-specific actions of a human LHX3 gene enhancer during pituitary and spinal cord development.

Soyoung Park1, Rachel D Mullen, Simon J Rhodes.   

Abstract

The LIM class of homeodomain protein 3 (LHX3) transcription factor is essential for pituitary gland and nervous system development in mammals. In humans, mutations in the LHX3 gene underlie complex pediatric syndromes featuring deficits in anterior pituitary hormones and defects in the nervous system. The mechanisms that control temporal and spatial expression of the LHX3 gene are poorly understood. The proximal promoters of the human LHX3 gene are insufficient to guide expression in vivo and downstream elements including a conserved enhancer region appear to play a role in tissue-specific expression in the pituitary and nervous system. Here we characterized the activity of this downstream enhancer region in regulating gene expression at the cellular level during development. Human LHX3 enhancer-driven Cre reporter transgenic mice were generated to facilitate studies of enhancer actions. The downstream LHX3 enhancer primarily guides gene transcription in α-glycoprotein subunit -expressing cells secreting the TSHβ, LHβ, or FSHβ hormones and expressing the GATA2 and steroidogenic factor 1 transcription factors. In the developing nervous system, the enhancer serves as a targeting module active in V2a interneurons. These results demonstrate that the downstream LHX3 enhancer is important in specific endocrine and neural cell types but also indicate that additional regulatory elements are likely involved in LHX3 gene expression. Furthermore, these studies revealed significant gonadotrope cell heterogeneity during pituitary development, providing insights into the cellular physiology of this key reproductive regulatory cell. The human LHX3 enhancer-driven Cre reporter transgenic mice also provide a valuable tool for further developmental studies of cell determination and differentiation in the pituitary and nervous system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100213      PMCID: PMC3857196          DOI: 10.1210/me.2013-1161

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  72 in total

1.  Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types.

Authors:  J S Dasen; S M O'Connell; S E Flynn; M Treier; A S Gleiberman; D P Szeto; F Hooshmand; A K Aggarwal; M G Rosenfeld
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

2.  LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions.

Authors:  Joshua P Thaler; Soo-Kyung Lee; Linda W Jurata; Gordon N Gill; Samuel L Pfaff
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

3.  Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes.

Authors:  T Tsuchida; M Ensini; S B Morton; M Baldassare; T Edlund; T M Jessell; S L Pfaff
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

4.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

Review 5.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

6.  Two promoters mediate transcription from the human LHX3 gene: involvement of nuclear factor I and specificity protein 1.

Authors:  Benjamin C Yaden; Marin Garcia; Timothy P L Smith; Simon J Rhodes
Journal:  Endocrinology       Date:  2005-09-22       Impact factor: 4.736

7.  In vivo genetic ablation by Cre-mediated expression of diphtheria toxin fragment A.

Authors:  Anna Ivanova; Massimo Signore; Nadia Caro; Nicholas D E Greene; Andrew J Copp; Juan Pedro Martinez-Barbera
Journal:  Genesis       Date:  2005-11       Impact factor: 2.487

8.  Transgenic mice expressing LHX3 transcription factor isoforms in the pituitary: effects on the gonadotrope axis and sex-specific reproductive disease.

Authors:  Jesse J Savage; Rachel D Mullen; Kyle W Sloop; Stephanie C Colvin; Sally A Camper; Craig L Franklin; Simon J Rhodes
Journal:  J Cell Physiol       Date:  2007-07       Impact factor: 6.384

9.  Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function.

Authors:  Michael A Charles; Thomas L Saunders; William M Wood; Kailey Owens; A F Parlow; Sally A Camper; E C Ridgway; David F Gordon
Journal:  Mol Endocrinol       Date:  2006-03-16

10.  Mutations in the LHX3 gene cause dysregulation of pituitary and neural target genes that reflect patient phenotypes.

Authors:  Jesse J Savage; Chad S Hunter; Surilda L Clark-Sturm; Tanya M Jacob; Roland W Pfaeffle; Simon J Rhodes
Journal:  Gene       Date:  2007-06-07       Impact factor: 3.688

View more
  4 in total

1.  Overexpression of Lhx8 inhibits cell proliferation and induces cell cycle arrest in PC12 cell line.

Authors:  Haoming Li; Jianbing Qin; Guohua Jin; Linqing Zou; Jinhong Shi; Xiao Han; Xiang Cheng; Xinhua Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-05       Impact factor: 2.416

2.  A regulatory sequence from the retinoid X receptor γ gene directs expression to horizontal cells and photoreceptors in the embryonic chicken retina.

Authors:  Maria K E Blixt; Finn Hallböök
Journal:  Mol Vis       Date:  2016-12-14       Impact factor: 2.367

Review 3.  Review on Genomic Regions and Candidate Genes Associated with Economically Important Production and Reproduction Traits in Sheep (Ovies aries).

Authors:  Gebremedhin Gebreselassie; Haile Berihulay; Lin Jiang; Yuehui Ma
Journal:  Animals (Basel)       Date:  2019-12-23       Impact factor: 2.752

4.  Gene targeting of mouse Tardbp negatively affects Masp2 expression.

Authors:  Samar Dib; Shangxi Xiao; Denise Miletic; Janice Robertson
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.